revealed that unlike PD-L1(+) tumors, PD-L1 expression in CTCs was associated with survival in metastatic BC, indicating a potential role of PD-L1(+)-CTCs as a stratifying factor for anti-PD-1/PD-L1 treatment for metastatic BC patients (171). Here, CD274 is linked to breast cancer.